Specifica

Specifica is an antibody engineering company headquartered in Santa Fe, New Mexico, United States. It specializes in the creation of exceptional antibody libraries using next-generation sequencing for quality control at all steps of construction and validation. The company's patented Generation 3 Antibody Library Discovery Platform yields drug-like antibodies directly from selections, minimizing the need for downstream affinity and biophysical engineering. Specifica offers antibody library platforms in Fab, scFv, and VHH formats, with scFv and Fab also available in fixed light chain format. The company provides its partners with exclusive libraries, each created from a unique donor diversity set not used for any other library, ensuring that each Generation 3 library is one of a kind. Specifica also offers antibody discovery and optimization campaigns, full platform transfer, and AbXtract, a suite of antibody informatics tools available through its software partner OpenEye. Specifica is part of IQVIA Laboratories, a global leader in drug discovery and development laboratory services. The company's scientists bring decades of expertise in developing innovative antibody libraries and delivering developable antibody drug leads to pharma and biotech companies. Specifica's platform has been chosen by 9 of the top 20 pharmaceutical companies. The company is located in The Railyard, the new heart of Santa Fe, New Mexico.

Specifica is an antibody engineering company based in Santa Fe, New Mexico. It was founded to specialize in the creation of antibody libraries using next-generation sequencing for quality control. The company developed its patented Generation 3 Antibody Library Discovery Platform, which yields drug-like antibodies directly from selections. Specifica has collaborated with pharmaceutical and biotechnology companies, providing exclusive libraries and discovery services. It introduced AbXtract, a suite of antibody informatics tools, through its software partner OpenEye. At some point, Specifica became part of IQVIA Laboratories, a global leader in drug discovery and development laboratory services. As of its official website, Specifica is headquartered in The Railyard in Santa Fe, New Mexico, and continues to offer antibody discovery and optimization campaigns, full platform transfer, and R&D services.

Specifica positions itself as a provider of drug-like antibodies directly from selections, with high affinity and developability, saving partners time and money. It emphasizes exclusive libraries and full platform transfer to empower discovery at partner sites.

• Generation 3 Antibody Library Discovery Platform

  Patented platform yielding drug-like antibodies directly from selections, with high affinity and developability.

• AbXtract

  Suite of antibody informatics tools available through software partner OpenEye.

• VHH libraries

  Antibody libraries in VHH format.

• Fab and scFv libraries

  Antibody libraries in Fab and scFv formats, also available in fixed light chain format.

1. 1Homespecifica.bio
2. 2Contactspecifica.bio
3. 3About Usspecifica.bio
4. 4Research and Development Servicesspecifica.bio
5. 5Specifica (United States)wikidata.org
6. 6Specifica Partners With Scholar Rock to Design and Create Antibody Display Library for Therapeutic Biologic Discoveryprnewswire.com